Study uncovers trends in the global burden of tracheal, bronchus, and lung cancer

by Cactus CommunicationsAge-specific rates of incidence, mortality, and DALY for TBL cancer by sex globally in 2019. A–C: Age-specific incidence rates in the whole population (A), males (B), and femal

Updated on: February 23,2024 11

Study uncovers trends in the global burden of tracheal, bronchus, and lung cancer

by Cactus CommunicationsAge-specific rates of incidence, mortality, and DALY for TBL cancer by sex globally in 2019. A–C: Age-specific incidence rates in the whole population (A), males (B), and femal

Updated on:February 23,2024 11

Scientists discover new survival strategy for oxygen-starved pancreatic cancer cells

by Monica May,Sanford Burnham Prebys Medical Discovery InstituteCredit: CC0 Public DomainOxygen is essential to life. When fast-growing tumor cells run out of oxygen, they quickly sprout new blo

Updated on: March 12,2024 13

Scientists discover new survival strategy for oxygen-starved pancreatic cancer cells

by Monica May,Sanford Burnham Prebys Medical Discovery InstituteCredit: CC0 Public DomainOxygen is essential to life. When fast-growing tumor cells run out of oxygen, they quickly sprout new blo

Updated on:March 12,2024 13

Proving the efficacy of local treatment in liver cancer oligometastases

by Korea University College of MedicineThe inclusion process. Credit:Cancers(2023). DOI: 10.3390/cancers15133467Professor Chai Hong Rim of the Department of Radiation Oncology, Korea Unive

Updated on: April 14,2024 11

Proving the efficacy of local treatment in liver cancer oligometastases

by Korea University College of MedicineThe inclusion process. Credit:Cancers(2023). DOI: 10.3390/cancers15133467Professor Chai Hong Rim of the Department of Radiation Oncology, Korea Unive

Updated on:April 14,2024 11

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Updated on: February 18,2024 14

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Updated on:February 18,2024 14

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on: June 01,2024 3

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on:June 01,2024 3

New spatial tool shows cancer cells rev up synthesis, compared with neighbors

by Talia Ogliore,Washington University in St. LouisMass spectrometry imaging with stable isotope labeling workflow.aMice with orthotopic brain tumors were fed an unlabeled or U−13C g

Updated on: January 12,2024 10

New spatial tool shows cancer cells rev up synthesis, compared with neighbors

by Talia Ogliore,Washington University in St. LouisMass spectrometry imaging with stable isotope labeling workflow.aMice with orthotopic brain tumors were fed an unlabeled or U−13C g

Updated on:January 12,2024 10

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Updated on: March 30,2024 0

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Updated on:March 30,2024 0

3-D scaffold map to help the search for new cancer treatments

by Walter and Eliza Hall Institute of Medical ResearchScientists have solved the 3-D structure of molecular scaffold SgK223, which is known to play a critical role in the development and spread o

Updated on: March 14,2024 19

3-D scaffold map to help the search for new cancer treatments

by Walter and Eliza Hall Institute of Medical ResearchScientists have solved the 3-D structure of molecular scaffold SgK223, which is known to play a critical role in the development and spread o

Updated on:March 14,2024 19

Team identifies genes that increase risk for triple-negative breast cancer

by Mayo ClinicThis stylistic diagram shows a gene in relation to the double helix structure of DNA and to a chromosome (right). The chromosome is X-shaped because it is dividing. Introns are regi

Updated on: May 27,2024 4

Team identifies genes that increase risk for triple-negative breast cancer

by Mayo ClinicThis stylistic diagram shows a gene in relation to the double helix structure of DNA and to a chromosome (right). The chromosome is X-shaped because it is dividing. Introns are regi

Updated on:May 27,2024 4

Private and secure generative AI tool supports operations and research in a cancer center

byDana-Farber Cancer InstituteCredit: CC0 Public DomainDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or ho

Updated on: March 30,2024 0

Private and secure generative AI tool supports operations and research in a cancer center

byDana-Farber Cancer InstituteCredit: CC0 Public DomainDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or ho

Updated on:March 30,2024 0

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on: May 11,2024 6

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on:May 11,2024 6

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa

Updated on: February 18,2024 19

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa

Updated on:February 18,2024 19